Clopidogrel Beats Aspirin at Its Own Game—14% Better Prevention, No Increased Risk
For decades, aspirin has been the go-to antiplatelet drug in the prevention of heart attacks and strokes. It earned its reputation as a “wonder drug” for cardiovascular disease prevention. But new research suggests the tide may be turning. At the recent European Society of Cardiology Congress, a major meta-analysis revealed that clopidogrel (Plavix) is 14% […]







